Requirements for the drug for injection into superficial facial fat pads: safety for the patient and efficacy

Age-related changes in the face in the deformation type of aging are manifested by the presence of swelling of facial tissues, lymphostasis phenomena, deformation changes in the contours and oval of the face. This process is largely associated with involutional changes in adipose tissue and the microcirculation system in superficial and deep fat packages. Simultaneously with the migration of fat packages, a redistribution of volume occurs in them - mainly atrophy of deep fat packages and hypertrophy of the superficial (nasolabial, lateral and medial mandibular, submandibular) with a simultaneous increase in fluid in the intercellular space due to microcirculation disorders. Accumulations of fat and water in these packages significantly distort the contours and volumes of the face, form the so-called "flews", "second chin" raquo;, the severity of nasolabial folds increases, etc. As a result, such a redistribution of volumes betrays the age of our patients.  In cosmetology, there is a large class of drugs aimed at reducing the volume & nbsp; adipose tissue. Lipolitics for working in facial tissues have different efficiencies. Which of them are optimal, considered estet-portal.com.

Mechanisms of action and key qualities of facial lipolytics

Lipolitic is a substance that can destroy the walls of fat cells and promote the removal of excess fat from the body. The substances used today in cosmetology have direct lipolytic properties – sodium deoxycholate and phosphatidylcholine. They dissolve the wall of the adipocyte, the triglycerides contained in the cell are released into the blood and utilized.

Studies on fibroblast culture have shown that these substances are very different in the mechanism of action on the cell of the fat package – adipocyte:
•    sodium deoxycholate –  breaks the cell membrane of adipocytes with the release of triglycerides into the extracellular space, does not have a selective effect, but destroys everything in its path, making no difference between adipocytes and other structures, including fibroblasts;
•    phosphatidylcholine – carries out the splitting of triglycerides in the extracellular space with the formation of fat drops, fat drops are digested by macrophages and multinucleated giant cells, i.e. fat is excreted from the body in a natural physiological way,

The use of lipolytics for the face of direct non-selective action carries a high risk of side effects, up to necrosis and other complications. The use of selective lipolytics is safe enough, but this is a traumatic process for correcting superficial fat pads, & nbsp; and recommended  for use no higher than the jawline.

Today, lipo-modifiers are replacing lipopolitics – drugs with atraumatic action, tissue-specific and safe, as MESOSCULPT

TM ^C71.

MESOSCULPT

ТМ ^{C71 from} EmetТМ allows you to act on facial fat with the effectiveness of surgical intervention, but at the same time it is absolutely safe for the patient.

Efficacy and safety of the policy for a person with modifying action

The peculiarity of the MESOSCULPT

ТМ^{C71 lipomodifier is that it does not destroy the fat cell, like all known direct lipolytics, but reduces its volume, inhibits the processes of division and  lipogenesis  adipocyte.}

The main active ingredient of the lipomodifier MESOSCULPT

ТМ ^{C71 — this is a unique patented LipoBlock XP2 complex, which, when injected into adipose tissue, reduces the size of each fat cell without destroying or destroying it, regulates the formation of new adipocytes and physiologically helps to reduce the volume of fat droplets in existing cells. This allows  correct effectively  volumes  superficial fat packs  face and is absolutely safe for the patient, since it does not carry the risk of complications associated with the destruction of cells.}

MESOSCULPT

TM ^{C71 prevents the formation of new fat cells and their increase in volume. This action does not exist in any other preparation for reducing the volume of adipose tissue.}

Another active ingredient of MESOSCULPT

ТМ ^{C71 — Hexapeptide 17, which provides elimination  edema  adipose tissue, restoration of the necessary microcirculation, so that the effect is visible quickly enough. Hexapeptide 17 provides  the first stage of the drug. The effect of LipoBlock XP2 is noticeable after 2 weeks, this is the period determined to re-evaluate the results of the correction and the need for re-injection.}

The action of MESOSCULPT

ТМ ^{C71 can be compared with a natural decrease in the volume of adipose tissue during active physical exertion, which is absolutely safe for the health and further life of cells.}The third active component of MESOSCULPT
ТМ ^{C71 – it is a dermo-remodeling complex of hyaluronic acid, nucleosides, vitamins, amino acids. It is responsible for improving the quality of the skin, starting reparative processes, and providing a lifting effect.}

Met

TM  passed numerous clinical trials, which confirmed its safety for patients. Its ability to influence adipose tissue at the epigenetic level, control the formation of adipose tissue and activate the processes of its resorption make MESOSCULPT^tm C71 one of the most effective means of correcting superficial fat deposits in complex facial rejuvenation programs.